Standardized Expression of F-18-NAV4694 and C-11-PiB beta-Amyloid PET Results with the Centiloid Scale
Christopher C Rowe, Gareth Jones, Vincent Dore, Svetlana Pejoska, Laura Margison, Rachel S Mulligan, J Gordon Chan, Kenneth Young, Victor L Villemagne
Journal of Nuclear Medicine | SOC NUCLEAR MEDICINE INC | Published : 2016
Awarded by National Health Medical Research Council (NHMRC) of Australia
The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. Cristopher Rowe has received research grants for imaging in dementia from Bayer-Schering Pharma, Avid Radiopharmaceuticals, GE Healthcare, Piramal, Astra Zeneca, and Navidea. He has been a consultant or paid speaker at sponsored conference sessions for Bayer-Schering Pharma, Piramal, GE Healthcare, Astra Zeneca, Roche, and Janssen. Victor Villemagne has been a consultant or paid speaker at sponsored conference sessions for Bayer-Schering Pharma, Piramal, GE Healthcare, Astra Zeneca, and Novartis. The study was partially supported by grants 1044361 and 1071430 from the National Health Medical Research Council (NHMRC) of Australia and by a research grant for imaging in dementia from Navidea. The funding sources had no input into the design or conduct of the study; the collection, management, analysis, or interpretation of the data; the preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication. No other potential conflict of interest relevant to this article was reported.